Fifth Third Bancorp’s Arcturus Therapeutics ARCT Stock Holding History

Fifth Third Bancorp’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-368	Closed	-$2.26K	–	4307
2025 Q4	$2.26K	Sell	368 -132	-26%	-$1.43K	﹤0.01%	2420
2025 Q3	$9.21K	Buy	+500	New	+$8.03K	﹤0.01%	2170
2025 Q1	–	Sell	-500	Closed	-$8.48K	–	2522
2024 Q4	$8.48K	Hold	500	–	–	﹤0.01%	2025
2024 Q3	$11.6K	Hold	500	–	–	﹤0.01%	1948
2024 Q2	$12.2K	Hold	500	–	–	﹤0.01%	1871
2024 Q1	$16.9K	Hold	500	–	–	﹤0.01%	1701
2023 Q4	$15.8K	Hold	500	–	–	﹤0.01%	1838
2023 Q3	$12.8K	Hold	500	–	–	﹤0.01%	1884
2023 Q2	$14.3K	Hold	500	–	–	﹤0.01%	1859
2023 Q1	$12K	Hold	500	–	–	﹤0.01%	2035
2022 Q4	$8.48K	Hold	500	–	–	﹤0.01%	2024
2022 Q3	$7K	Hold	500	–	–	﹤0.01%	2056
2022 Q2	$8K	Hold	500	–	–	﹤0.01%	2066
2022 Q1	$13K	Hold	500	–	–	﹤0.01%	1949
2021 Q4	$19K	Hold	500	–	–	﹤0.01%	1864
2021 Q3	$24K	Hold	500	–	–	﹤0.01%	1723
2021 Q2	$17K	Hold	500	–	–	﹤0.01%	1838
2021 Q1	$21K	Hold	500	–	–	﹤0.01%	1756
2020 Q4	$22K	Hold	500	–	–	﹤0.01%	1675
2020 Q3	$21K	Hold	500	–	–	﹤0.01%	1555
2020 Q2	$23K	Buy	500 +300	+150%	+$10.3K	﹤0.01%	1504
2020 Q1	$3K	Hold	200	–	–	﹤0.01%	1922
2019 Q4	$2K	Hold	200	–	–	﹤0.01%	2049
2019 Q3	$2K	Buy	+200	New	+$2.16K	﹤0.01%	2036

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fifth Third Bancorp's ARCT Position: Q1 2026 in Review

Fifth Third Bancorp sold out of Arcturus Therapeutics (ARCT) in Q1 2026, closing a stake of 368 shares — an estimated $2.26K sold.

Fifth Third Bancorp first reported a position in ARCT in Q3 2019 and held it in 24 quarters. The position peaked at $24K in Q3 2021. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

Fifth Third Bancorp reported no remaining Arcturus Therapeutics position as of Q1 2026 after selling out during the quarter.
Fifth Third Bancorp sold 368 Arcturus Therapeutics shares in Q1 2026, an estimated $2.26K.
Fifth Third Bancorp first reported a position in Arcturus Therapeutics in Q3 2019 and held it in 24 quarters.
Fifth Third Bancorp's Arcturus Therapeutics position peaked at $24K in Q3 2021.
124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.